743.76 - 757.57
479.80 - 796.25
8.25M / 11.73M (Avg.)
27.40 | 27.58
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-10.94%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-5.42%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-28.72%
Negative EBIT growth while BIDU is at 8.43%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-28.72%
Negative operating income growth while BIDU is at 8.43%. Joel Greenblatt would press for urgent turnaround measures.
22.70%
Net income growth 1.25-1.5x BIDU's 17.61%. Bruce Berkowitz would see if strategic cost cutting or product mix explains this difference.
25.57%
EPS growth 1.25-1.5x BIDU's 17.44%. Bruce Berkowitz would check if strategic initiatives like cost cutting or better capital management explain the difference.
25.00%
Diluted EPS growth 1.25-1.5x BIDU's 17.06%. Bruce Berkowitz would verify if strategic moves (e.g., targeted acquisitions, cost cuts) explain the edge.
-1.93%
Share reduction while BIDU is at 0.32%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-1.67%
Reduced diluted shares while BIDU is at 1.29%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
-3.54%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
30.87%
Positive FCF growth while BIDU is negative. John Neff would see a strong competitive edge in net cash generation.
1780.52%
10Y revenue/share CAGR above 1.5x BIDU's 421.70%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
172.46%
5Y revenue/share CAGR above 1.5x BIDU's 48.38%. David Dodd would look for consistent product or market expansions fueling outperformance.
78.96%
3Y revenue/share CAGR above 1.5x BIDU's 36.56%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
1763.47%
10Y OCF/share CAGR above 1.5x BIDU's 167.16%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
102.70%
OCF/share CAGR of 102.70% while BIDU is zero. Bruce Berkowitz would see if modest momentum can translate into a bigger competitive lead.
41.00%
3Y OCF/share CAGR under 50% of BIDU's 162.78%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
2418.18%
Net income/share CAGR above 1.5x BIDU's 185.09% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
30.29%
Positive 5Y CAGR while BIDU is negative. John Neff might view this as a strong mid-term relative advantage.
29.05%
Below 50% of BIDU's 13944.83%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
910.23%
10Y equity/share CAGR 1.25-1.5x BIDU's 712.38%. Bruce Berkowitz would see if strong ROE or conservative payout policy fosters faster book value growth.
82.99%
5Y equity/share CAGR is in line with BIDU's 84.09%. Walter Schloss would see parallel mid-term profitability and retention policies.
31.32%
3Y equity/share CAGR at 75-90% of BIDU's 39.51%. Bill Ackman pushes for margin or operational changes to match the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-17.99%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
No Data
No Data available this quarter, please select a different quarter.
-0.67%
Negative asset growth while BIDU invests at 2.56%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
1.23%
Under 50% of BIDU's 3.77%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
3.70%
Debt growth far above BIDU's 3.36%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
-3.99%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-22.59%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.